M90.619 Osteitis deformans in neoplastic diseases, unspecified shoulder

Name of the Condition

• Osteitis deformans in neoplastic diseases, unspecified shoulder

Summary

Osteitis deformans in neoplastic diseases, unspecified shoulder (ICD Code M90.619) refers to a bone disorder characterized by abnormal bone remodeling, occurring as a secondary manifestation of neoplastic (cancerous) conditions. This condition involves structural changes in bone tissue due to the underlying malignancy, which disrupts normal bone metabolism and can lead to deformities or other complications in the shoulder region.

Causes

The primary cause is the presence of neoplastic diseases, such as primary bone tumors or metastatic cancer, which affect bone tissue. These malignancies can stimulate abnormal bone formation or resorption, leading to the characteristic changes of osteitis deformans. The underlying cancer drives the bone pathology in the shoulder area.

Risk Factors

• History of malignancy (primary or metastatic)
• Advanced age
• Prolonged exposure to certain neoplastic processes
• Genetic predisposition to bone disorders
• Prior radiation therapy to the shoulder area

Symptoms

• Shoulder pain or discomfort
• Reduced range of motion in the shoulder joint
• Swelling or deformity around the shoulder
• Weakness or instability in the affected arm
• Possible nerve compression symptoms (e.g., numbness, tingling)

Diagnosis

Diagnosis requires correlation of clinical findings with the underlying neoplastic disease. Imaging studies (X-rays, MRI, or CT) assess bone changes, while laboratory tests may evaluate bone metabolism markers. Biopsy of the affected shoulder tissue may be necessary to confirm the neoplastic origin and rule out other conditions.

Treatment Options

Treatment focuses on managing the underlying neoplastic disease and addressing bone-related symptoms. This may include cancer therapies (chemotherapy, radiation, or surgery), pain management, physical therapy to maintain shoulder function, and medications to regulate bone turnover (e.g., bisphosphonates). Surgical intervention may be considered for severe deformities or fractures.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying neoplastic disease. Regular follow-up is essential to monitor bone changes, manage symptoms, and adjust treatment as needed. Long-term surveillance helps detect complications early and optimize shoulder function.

Complications

• Chronic shoulder pain or disability
• Increased risk of fractures in the shoulder
• Nerve compression leading to sensory or motor deficits
• Progressive bone deformity affecting mobility
• Reduced quality of life due to functional limitations

Lifestyle & Prevention

• Maintain a balanced diet rich in calcium and vitamin D to support bone health.
• Engage in gentle shoulder exercises to preserve range of motion, as advised by a healthcare provider.
• Avoid activities that strain the shoulder joint to reduce injury risk.
• Follow recommended cancer screening and treatment plans to manage the underlying neoplastic condition.

When to Seek Professional Help

Seek medical attention if you experience persistent shoulder pain, sudden swelling, reduced mobility, or signs of nerve compression (e.g., numbness, weakness). Prompt evaluation is critical if the shoulder becomes unstable or if fractures are suspected.

Tips for Medical Coders

When coding M90.619, ensure the documentation specifies the shoulder as the affected site and links the osteitis deformans to a neoplastic disease. Verify that the underlying malignancy is clearly documented, as this code is specific to secondary bone changes in cancer. Avoid using this code for primary Paget's disease or non-neoplastic causes of shoulder deformity.